{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:11:57Z","timestamp":1789517517939,"version":"build-2803163510"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Arginine deprivation therapy (ADT) hinders glioma cells\u2019 access to nutrients by reducing peripheral blood arginine, showing great efficacy in various studies, which suggests it as a potentially promising treatment for glioma. The aim of this systematic review was to explore the mechanism of ADT for gliomas, the therapeutic effect based on existing research, and possible combination therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a systematic literature review of PubMed, ScienceDirect and Web of Science databases according to PRISMA guidelines, searching for articles on the efficacy of ADT in glioma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 17 studies among 786 search results, among which ADT therapy mainly based on Arginine free condition, Arginine Deiminase and Arginase, including three completed clinical trials. ADT therapy has shown promising results <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic>, with its safety confirmed in clinical trials. In the early phase of treatment, glioblastoma (GBM) cells develop protective mechanisms of stress and autophagy, which eventually evolve into caspase dependent apoptosis or senescence, respectively. The immunosuppressive microenvironment is also altered by arginine depletion, such as the transformation of microglia into a pro-inflammatory phenotype and the activation of T-cells. Thus, ADT therapy demonstrates glioma-killing effect in the presence of a combination of mechanisms. In combination with various conventional therapies and investigational drugs such as radiotherapy, temozolomide (TMZ), cyclin-dependent kinase inhibitors (CDK) inhibitors and autophagy inducers, ADT therapy has been shown to be more effective. However, the phenomenon of drug resistance due to re-expression of ASS1 rather than stem cell remains to be investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Despite the paucity of studies in the literature, the available data demonstrate the therapeutic potential of arginine deprivation therapy for glioma and encourage further research, especially the exploration of its combination therapies and the extrapolation of what we know about the effects and mechanisms of ADT from other tumors to glioma.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1446725","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T08:08:39Z","timestamp":1724314119000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic potential of arginine deprivation therapy for gliomas: a systematic review of the existing literature"],"prefix":"10.3389","volume":"15","author":[{"given":"Chen","family":"Yuxiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Jiachen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Yanjie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shenglan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wenbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"B1","article-title":"ER stress and inflammation crosstalk in obesity - PubMed","author":"Ajoolabady","year":"2023"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.3390\/cancers14194817","article-title":"Nerve density and neuronal biomarkers in cancer","volume":"14","author":"Ali","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in tar-geted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes and Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"9137","DOI":"10.3390\/ijms24119137","article-title":"Glioblastoma metabolism: insights and therapeutic strategies","volume":"24","author":"Bernhard","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41568-019-0226-5","article-title":"Altered cellular metabolism in gliomas \u2014 an emerging landscape of actionable co-dependency targets","volume":"20","author":"Bi","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9008685","article-title":"Characterisation of expression the arginine pathway enzymes in childhood brain tumours to determine susceptibility to therapeutic arginine depletion","author":"Bishop","year":"2022","journal-title":"BioMed Res. Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.biocel.2015.10.027","article-title":"Arginine deprivation induces endoplasmic reticulum stress in human solid cancer cells","volume":"70","author":"Bobak","year":"2016","journal-title":"Int. J. Biochem. and Cell Biol."},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.2057","volume-title":"Phase IB trial of pegylated arginine deiminase (ADI-PEG 20) plus radiotherapy and temozolomide in patients with newly diagnosed glioblastoma","author":"Bomalaski","year":"2022"},{"key":"B9","doi-asserted-by":"publisher","first-page":"16584","DOI":"10.1021\/jp105606b","article-title":"Distance-dependent diffusion-controlled reaction of \u2022NO and O2\u2022\u2212 at chemical equilibrium with ONOO","volume":"114","author":"Botti","year":"2010","journal-title":"J. Phys. Chem. B"},{"key":"B10","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41419-020-02899-8","article-title":"Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogram-ming","volume":"11","author":"Brashears","year":"2020","journal-title":"Cell Death Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"22950","DOI":"10.1038\/srep22950","article-title":"Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine dei-minase (ADI-PEG20)","volume":"6","author":"Burrows","year":"2016","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"153848","DOI":"10.1016\/j.tetlet.2022.153848","article-title":"Canavanine versus arginine: prospects for cell-penetrating peptides","volume":"99","author":"Calabretta","year":"2022","journal-title":"Tet-rahedron Lett."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.7150\/thno.53506","article-title":"Beyond glucose: alternative sources of energy in glioblastoma","volume":"11","author":"Caniglia","year":"2021","journal-title":"Theranostics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.3390\/cancers13143541","article-title":"Arginine signaling and cancer metabolism","volume":"13","author":"Chen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B15","volume-title":"Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivatio","author":"Cheng","year":"2008"},{"key":"B16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s11060-016-2209-7","article-title":"Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg)","volume":"129","author":"Choy","year":"2016","journal-title":"J. Neurooncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/s41598-017-01696-2","article-title":"Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer","volume":"7","author":"Dauer","year":"2017","journal-title":"Sci. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.soncn.2018.10.001","article-title":"Epidemiology and overview of gliomas","volume":"34","author":"Davis","year":"2018","journal-title":"Semin. Oncol. Nurs."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1126\/science.1063518","article-title":"Mammalian tor: a homeostatic ATP sensor","volume":"294","author":"Dennis","year":"2001","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","first-page":"905893","DOI":"10.3389\/fonc.2022.905893","article-title":"Arginase: mechanisms and clinical application in hematologic malignancy","volume":"12","author":"Du","year":"2022","journal-title":"Front. Oncol."},{"key":"B21","first-page":"5443","article-title":"Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo","volume":"62","author":"Ensor","year":"2002","journal-title":"Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2162-3619-2-11","article-title":"Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment","volume":"2","author":"F","year":"2013","journal-title":"Exp. Hematol. and Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1296576","DOI":"10.3389\/fonc.2024.1296576","article-title":"PARC: a phase I\/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed\/refractory cancers of children and young adults","volume":"14","author":"Fenwick","year":"2024","journal-title":"Front. Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1080\/15384047.2015.1026478","article-title":"Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo","volume":"16","author":"Fiedler","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"107956","DOI":"10.1016\/j.isci.2023.107956","article-title":"EDEM1 regulates the insulin mRNA level by inhibiting the endoplasmic reticulum stress-induced IRE1\/JNK\/c-Jun pathway","volume":"26","author":"Flintoaca Alexandru","year":"2023","journal-title":"iScience"},{"key":"B26","doi-asserted-by":"publisher","first-page":"105420","DOI":"10.1016\/j.tiv.2022.105420","article-title":"Quinacrine is active in preclinical models of glioblastoma through suppressing angiogenesis, inducing oxidative stress and activating AMPK","volume":"83","author":"Fu","year":"2022","journal-title":"Toxicol Vitro"},{"key":"B27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ijc.30051","article-title":"Molecular basis and current strategies of therapeutic arginine depletion for cancer","volume":"139","author":"Fultang","year":"2016","journal-title":"Int. J. Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12885-017-3058-2","article-title":"Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species","volume":"17","author":"Gersey","year":"2017","journal-title":"BMC Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1038\/s41467-019-10606-1","article-title":"Structural basis for the inhibition of translation through eIF2\u03b1 phosphor-ylation","volume":"10","author":"Gordiyenko","year":"2019","journal-title":"Nat. Commun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e142137","DOI":"10.1172\/JCI142137","article-title":"Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors","volume":"132","author":"Hajji","year":"2022","journal-title":"J. Clin. Invest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1158\/1078-0432.CCR-18-3729","article-title":"A phase I study of pegylated arginine deiminase (pegargiminase), cisplatin, and pemetrexed in Ar-gininosuccinate synthetase 1-deficient recurrent high-grade glioma","volume":"25","author":"Hall","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.3390\/cells10123529","article-title":"Glioblastoma: relationship between me-tabolism and immunosuppressive microenvironment","volume":"10","author":"Hern\u00e1ndez","year":"2021","journal-title":"Cells"},{"key":"B34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1158\/1535-7163.MCT-16-0807","article-title":"Arginine deprivation therapy: putative strategy to eradicate glioblastoma cells by radiosensitization","volume":"17","author":"Hinrichs","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s0168-3659(02)00042-1","article-title":"Poly(ethylene glycol) (PEG) conjugated argi-nine deiminase: effects of PEG formulations on its pharmacological properties","volume":"80","author":"Holtsberg","year":"2002","journal-title":"J. Control. Release"},{"key":"B36","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41416-020-0885-8","article-title":"CD133 inhibition via autophagic degradation in pemetrexed-resistant lung cancer cells by GMI, a fungal immunomodulatory protein from Ganoderma microsporum","volume":"123","author":"Hsin","year":"2020","journal-title":"Br. J. Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.mce.2014.02.005","article-title":"Cyclic adenosine monophosphate-induced argininosuccinate synthase 1 expression is essential during mouse decidualization","volume":"388","author":"Huang","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.3390\/curroncol30020147","article-title":"Temozolomide chronotherapy in glioma: a systematic review","volume":"30","author":"Jia","year":"2023","journal-title":"Curr. Oncol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrclinonc.2012.87","article-title":"Paediatric and adult malignant glioma: close relatives or distant cousins?","volume":"9","author":"Jones","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"14050","DOI":"10.1073\/pnas.0704014104","article-title":"The Atg5 Atg12 conjugate associates with innate antiviral immune responses","volume":"104","author":"Jounai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.3390\/cancers13143575","article-title":"HDAC inhibitors: dissecting mechanisms of action to counter tumor heterogeneity","volume":"13","author":"Karagiannis","year":"2021","journal-title":"Cancers (Basel)."},{"key":"B42","unstructured":"Arginylation of beta-actin regulates actin cytoskeleton and cell motility - PubMed\n            KarakozovaM.\n            KozakM.\n            WongC. C.\n          2006"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.3390\/cells9102217","article-title":"Combinatory treatment of canavanine and arginine deprivation efficiently targets human glioblastoma cells via pleiotropic mechanisms","volume":"9","author":"Karatsai","year":"2020","journal-title":"Cells"},{"key":"B44","doi-asserted-by":"publisher","first-page":"7317","DOI":"10.1038\/s41598-023-34404-4","article-title":"Activity of pemetrexed in pre-clinical chordoma models and humans","volume":"13","author":"Kesari","year":"2023","journal-title":"Sci. Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11060-014-1698-5","article-title":"Human recombinant arginase I (Co)-PEG5000 (HuArgI (Co)-PEG5000)-induced arginine depletion is se-lectively cytotoxic to human glioblastoma cells","volume":"122","author":"Khoury","year":"2015","journal-title":"J. Neurooncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"567","DOI":"10.4161\/auto.5.4.8252","article-title":"ADI, autophagy and apoptosis: metabolic stress as a therapeutic option for prostate cancer","volume":"5","author":"Kim","year":"2009","journal-title":"Autophagy"},{"key":"B47","doi-asserted-by":"publisher","first-page":"E183","DOI":"10.1002\/ajh.24066","article-title":"Temozolomide induced bone marrow Suppression\u2013A single institution outcome analysis and review of the literature","volume":"90","author":"Kourelis","year":"2015","journal-title":"Am. J. Hematol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.12786\/bn.2022.15.e24","article-title":"Treatment of adult gliomas: a current update","volume":"15","author":"Lee","year":"2022","journal-title":"Brain Neurorehabil"},{"key":"B49","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12935-023-02873-2","article-title":"The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glio-blastoma cells via ATF4 and cytochrome C","volume":"23","author":"Linke","year":"2023","journal-title":"Cancer Cell Int."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1080\/09553002.2020.1807641","article-title":"Role of DNA damage and repair in radiation cancer therapy: a current update and a look to the future","volume":"96","author":"Liu","year":"2020","journal-title":"Int. J. Radiat. Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","article-title":"Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.1038\/s41467-023-41567-1","article-title":"Endothelial Sp1\/Sp3 are essential to the effect of captopril on blood pressure in male mice","volume":"14","author":"Lu","year":"2023","journal-title":"Nat. Commun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"16597","DOI":"10.3390\/ijms242316597","article-title":"Therapeutic potential of resveratrol for glioma: a systematic review and meta-analysis of animal model studies","volume":"24","author":"Lu\u00eds","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cbi.2017.10.007","article-title":"Deciphering molecular mechanisms of arginine deiminase-based therapy \u2013 comparative response anal-ysis in paired human primary and recurrent glioblastomas","volume":"278","author":"Maletzki","year":"2017","journal-title":"Chemico-Biological Interact."},{"key":"B56","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"B57","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1593\/tlo.11262","article-title":"Recombinant human arginase toxicity in mice is reduced by citrulline supplementation","volume":"5","author":"Mauldin","year":"2012","journal-title":"Transl. Oncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","article-title":"Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion","volume":"14","author":"Mauthe","year":"2018","journal-title":"Autophagy"},{"key":"B59","unstructured":"LC3A-mediated autophagy regulates lung cancer cell plasticity - PubMed\n            MiaoC. C.\n            HwangW.\n            ChuL. Y.\n          2022"},{"key":"B60","unstructured":"Diffusion and transport of peroxynitrite across cell membranes 3 P\n            MollerM. N.\n            AllevaK.\n          2023"},{"key":"B61","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018","volume":"23","author":"Ostrom","year":"2021","journal-title":"Neuro-Oncology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00726-014-1857-1","article-title":"Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of \u03b2-actin arginylation","volume":"47","author":"Pavlyk","year":"2015","journal-title":"Amino Acids"},{"key":"B63","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. and Mol. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"703465","DOI":"10.3389\/fonc.2021.703465","article-title":"A novel oral arginase 1\/2 inhibitor enhances the antitumor effect of PD-1 inhibition in murine experi-mental gliomas by altering the immunosuppressive environment","volume":"11","author":"Pilanc","year":"2021","journal-title":"Front. Oncol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1158\/0008-5472.CAN-06-1945","article-title":"Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion","volume":"67","author":"Pn","year":"2007","journal-title":"Cancer Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/febs.15337","article-title":"Enzymology of the pathway for ATP production by arginine breakdown","volume":"288","author":"Pols","year":"2021","journal-title":"FEBS J."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41419-018-1195-4","article-title":"Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM","volume":"9","author":"Przystal","year":"2018","journal-title":"Cell Death Dis."},{"key":"B68","unstructured":"Activation of apoptosis signalling pathways by reactive oxygen species - ScienceDirect\n            Redza-DutordoirM.\n            Averill-BatesD. A.\n          2016"},{"key":"B69","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41419-022-05006-1","article-title":"Implementation of a combined CDK inhibition and arginine-deprivation approach to target argi-nine-auxotrophic glioblastoma multiforme cells","volume":"13","author":"Riess","year":"2022","journal-title":"Cell Death Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41420-021-00423-1","article-title":"Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models","volume":"7","author":"Riess","year":"2021","journal-title":"Cell Death Discov."},{"key":"B71","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1159\/000495382","article-title":"Arginine-depleting enzymes - an increasingly recognized treatment strategy for therapy-refractory ma-lignancies","volume":"51","author":"Riess","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"B72","doi-asserted-by":"publisher","first-page":"14579","DOI":"10.1038\/s41598-021-93780-x","article-title":"Growth arrest and DNA damage-inducible proteins (GADD45) in psoriasis","volume":"11","author":"Rodr\u00edguez-Jim\u00e9nez","year":"2021","journal-title":"Sci. Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41416-020-01136-5","article-title":"Tumour treating fields therapy for glioblastoma: current advances and future directions","volume":"124","author":"Rominiyi","year":"2021","journal-title":"Br. J. Cancer"},{"key":"B74","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41467-021-21147-x","article-title":"Regulatory inter-domain interactions influence Hsp70 recruitment to the DnaJB8 chaperone","volume":"12","author":"Ryder","year":"2021","journal-title":"Nat. Com-mun"},{"key":"B75","doi-asserted-by":"publisher","first-page":"126637","DOI":"10.1016\/j.bmcl.2019.126637","article-title":"Cyclin dependent kinase (CDK) inhibitors as anti-cancer drugs: recent advances (2015-2019)","volume":"29","author":"S\u00e1nchez-Mart\u00ednez","year":"2019","journal-title":"Bioorg Med. Chem. Lett."},{"key":"B76","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00253-021-11728-7","article-title":"PEGylation increases antitumoral activity of arginine deiminase of Streptococcus pyogenes","volume":"106","author":"Schwarz","year":"2022","journal-title":"Appl. Micro-biol Biotechnol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/oncolo\/oyac202","article-title":"Radiotherapy plus temozolomide with or without nimotuzumab against the newly diagnosed EGFR-positive glioblastoma: a retrospective cohort study","volume":"28","author":"She","year":"2022","journal-title":"Oncologist"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41419-021-04318-y","article-title":"PERK signaling through C\/EBP\u03b4 contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells","volume":"12","author":"Sheshadri","year":"2021","journal-title":"Cell Death Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"10373","DOI":"10.3390\/ijms221910373","article-title":"Prognostic and predictive biomarkers in gliomas","volume":"22","author":"\u015aledzi\u0144ska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s43587-021-00121-8","article-title":"Strategies for targeting senescent cells in human disease","volume":"1","author":"Gasek","year":"2022","journal-title":"Nat. Aging"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s11101-017-9536-y","article-title":"How does a simple non-protein amino acid inhibit cellular function in a diverse living system?","volume":"16","author":"Staszek","year":"2017","journal-title":"Phytochem. Rev."},{"key":"B81","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1021\/cb900267j","article-title":"Replacing Mn(2+) with Co(2+) in human arginase i enhances cytotoxicity toward l-arginine auxotrophic cancer cell lines","volume":"5","author":"Stone","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e458","DOI":"10.1038\/cddis.2012.197","article-title":"Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma","volume":"4","author":"Syed","year":"2013","journal-title":"Cell Death Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s10014-017-0284-x","article-title":"Bevacizumab for malignant gliomas: current indications, mechanisms of action and resistance, and markers of response","volume":"34","author":"Tamura","year":"2017","journal-title":"Brain Tumor Pathol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.leukres.2013.08.007","article-title":"Human recombinant arginase I(Co)-PEG5000 (HuArgI(Co)-PEG5000)-induced arginine depletion is selec-tively cytotoxic to human acute myeloid leukemia cells","volume":"37","author":"Tanios","year":"2013","journal-title":"Leuk. Res."},{"key":"B85","volume-title":"mTOR inhibits autophagy to facilitate cell swelling and rapid wound repair","author":"Tibbo","year":"2022"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41430-021-00943-0","article-title":"Amino acid metabolism and signalling pathways: potential targets in the control of infection and immunity","volume":"75","author":"Tom\u00e9","year":"2021","journal-title":"Eur. J. Clin. Nutr."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1158\/0008-5472.CAN-11-3605","article-title":"Activation of Ras\/PI3K\/ERK pathway induces c-myc stabilization to upregulate argininosuccinate syn-thetase, leading to arginine deiminase resistance in melanoma cells","volume":"72","author":"Tsai","year":"2012","journal-title":"Cancer Res."},{"key":"B88","unstructured":"Role of superoxide dismutases (SODs) in stress tolerance in plants SpringerLink\n            TyagiS.\n            Shumayla SinghS. P.\n          2019"},{"key":"B89","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s44194-024-00031-y","article-title":"Glioma-associated macrophages: unraveling their dual role in the microenvironment and therapeutic implications","volume":"3","author":"Wang","year":"2024","journal-title":"Curr. Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3389\/fimmu.2017.00864","article-title":"Reconstitution of T Cell proliferation under arginine limitation: activated human T cells take up cit-rulline via L-type amino acid transporter 1 and use it to regenerate arginine after induction of argininosuccinate synthase expression","volume":"8","author":"Werner","year":"2017","journal-title":"Front. Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/nu13030950","article-title":"Anticancer mechanism of curcumin on human glioblastoma","volume":"13","author":"Wong","year":"2021","journal-title":"Nutrients"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.02.002","article-title":"Immunotherapy for glioma: current management and future application","volume":"476","author":"Xu","year":"2020","journal-title":"Cancer Lett."},{"key":"B93","doi-asserted-by":"publisher","first-page":"9551","DOI":"10.1158\/0008-5472.CAN-08-2058","article-title":"Palomid 529, a novel small-molecule drug, is a TORC1\/TORC2 inhibitor that reduces tumor growth, tumor angiogenesis, and vascular permeability","volume":"68","author":"Xue","year":"2008","journal-title":"Cancer Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s10637-014-0200-8","article-title":"Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma","volume":"33","author":"Yau","year":"2015","journal-title":"Investig. New Drugs"},{"key":"B95","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41420-018-0103-0","article-title":"Inhibition of glioblastoma cell proliferation, invasion, and mechanism of action of a novel hydroxamic acid hybrid molecule","volume":"4","author":"Zhang","year":"2019","journal-title":"Cell Death Discov."},{"key":"B96","doi-asserted-by":"publisher","first-page":"12964","DOI":"10.1021\/acsnano.2c05408","article-title":"Arginine supplementation targeting tumor-killing immune cells reconstructs the tumor microenviron-ment and enhances the antitumor immune response","volume":"16","author":"Zhang","year":"2022","journal-title":"ACS Nano"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1446725\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T08:08:50Z","timestamp":1724314130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1446725\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":96,"alternative-id":["10.3389\/fphar.2024.1446725"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1446725","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"article-number":"1446725"}}